Clinical trials
Completed Overweight trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 8 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| Novo Nordisk A/S | 5 |
| Asir John Samuel | 1 |
| Bioagile Therapeutics Pvt. Ltd. | 1 |
| Diabetes Foundation, India | 1 |
| GlaxoSmithKline | 1 |
| Hofseth Biocare ASA | 1 |
| Maastricht University Medical Center | 1 |
| Nuritas Ltd | 1 |
| Vedic Lifesciences Pvt. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 19 |
| Obesity | 13 |
| Diabetes Mellitus, Type 2 | 5 |
| Nutrition Disorders | 3 |
| Pediatric Obesity | 2 |
| Sleep Apnea, Obstructive | 2 |
| Cardiovascular Diseases | 1 |
| Glucose Intolerance | 1 |
| Noncommunicable Diseases | 1 |
| Osteoarthritis, Knee | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.